Results 151 to 160 of about 141,658 (207)
Feasibility of tumor-informed circulating tumor DNA for detecting minimal residual disease in surgically resected biliary tract cancer. [PDF]
PLoS OnePark Y +8 more
europepmc +1 more source
Precision targeted-immunotherapy for BRAF V600E and MET-amplified biliary tract cancer: two case reports. [PDF]
OncologistHe X +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Lancet, 2021
Biliary tract cancers, including intrahepatic, perihilar, and distal cholangiocarcinoma as well as gallbladder cancer, are low-incidence malignancies in most high-income countries, but represent a major health problem in endemic areas; moreover, the incidence of intrahepatic cholangiocarcinoma is rising globally. Surgery is the cornerstone of cure; the
Juan W, Valle +4 more
openaire +4 more sources
Biliary tract cancers, including intrahepatic, perihilar, and distal cholangiocarcinoma as well as gallbladder cancer, are low-incidence malignancies in most high-income countries, but represent a major health problem in endemic areas; moreover, the incidence of intrahepatic cholangiocarcinoma is rising globally. Surgery is the cornerstone of cure; the
Juan W, Valle +4 more
openaire +4 more sources
New England Journal of Medicine, 1999
In the United States, an estimated 20,000 new cases of liver and biliary tract cancer are diagnosed annually.1 Biliary tract cancer is the second most common primary hepatobiliary cancer, after hepatocellular cancer. Approximately 7500 new cases of biliary tract cancer are diagnosed per year; about 5000 of these are gallbladder cancer, and between 2000
P C, de Groen +4 more
openaire +4 more sources
In the United States, an estimated 20,000 new cases of liver and biliary tract cancer are diagnosed annually.1 Biliary tract cancer is the second most common primary hepatobiliary cancer, after hepatocellular cancer. Approximately 7500 new cases of biliary tract cancer are diagnosed per year; about 5000 of these are gallbladder cancer, and between 2000
P C, de Groen +4 more
openaire +4 more sources
Current Treatment Options in Gastroenterology, 1998
Biliary pain resulting from motility disorders is common and may be overlooked due to the difficulty of diagnosing the presence of these disorders. A sound, logical approach to the evaluation and treatment of these specific groups of disorders is essential.
, Lichtenstein, , Dabezies
openaire +2 more sources
Biliary pain resulting from motility disorders is common and may be overlooked due to the difficulty of diagnosing the presence of these disorders. A sound, logical approach to the evaluation and treatment of these specific groups of disorders is essential.
, Lichtenstein, , Dabezies
openaire +2 more sources
Current Opinion in Gastroenterology, 2000
Investigation into the molecular and cellular biology of carcinogenesis continues to elucidate potential mechanisms for the initiation and progression of biliary tract cancer. The potential role of cell cycle regulators, such as Fas ligand, has been examined in the etiology of bile duct carcinoma.
J N, Cormier, J N, Vauthey
openaire +2 more sources
Investigation into the molecular and cellular biology of carcinogenesis continues to elucidate potential mechanisms for the initiation and progression of biliary tract cancer. The potential role of cell cycle regulators, such as Fas ligand, has been examined in the etiology of bile duct carcinoma.
J N, Cormier, J N, Vauthey
openaire +2 more sources
Military Medicine, 1990
A case of melanoma of the upper extremity with a solitary metastasis to the common bile duct is reported. A comprehensive review of melanoma in the biliary tree is presented. Antemortem diagnoses of such cases are rare but are associated with a high percentage of disease clinically confined to the biliary tree.
A J, Cohen +3 more
openaire +2 more sources
A case of melanoma of the upper extremity with a solitary metastasis to the common bile duct is reported. A comprehensive review of melanoma in the biliary tree is presented. Antemortem diagnoses of such cases are rare but are associated with a high percentage of disease clinically confined to the biliary tree.
A J, Cohen +3 more
openaire +2 more sources
Current Opinion in Gastroenterology, 1999
Recent advances in the molecular and cellular biology, diagnosis, and treatment of biliary tract cancer are reviewed. Several studies have delineated the molecular and cellular biology of cholangiocarcinoma and gallbladder carcinoma. Hepatocyte growth factor seems to be mitogenic to gallbladder carcinoma, and its inhibition may have a therapeutic role ...
J A, Ehrenfried, J N, Vauthey
openaire +2 more sources
Recent advances in the molecular and cellular biology, diagnosis, and treatment of biliary tract cancer are reviewed. Several studies have delineated the molecular and cellular biology of cholangiocarcinoma and gallbladder carcinoma. Hepatocyte growth factor seems to be mitogenic to gallbladder carcinoma, and its inhibition may have a therapeutic role ...
J A, Ehrenfried, J N, Vauthey
openaire +2 more sources
The American Journal of Surgery, 1951
Abstract 1. 1. Experience with 109 consecutive cases of biliary tract disease over a ten-year period from 1940 to 1950 demonstrates that no absolute rule can be applied in any series of cases. A guide to therapy is offered through the posing of three questions regarding the warranty of surgical intervention, proper time for surgery and operative ...
U, MAES, G N, WEISS
openaire +2 more sources
Abstract 1. 1. Experience with 109 consecutive cases of biliary tract disease over a ten-year period from 1940 to 1950 demonstrates that no absolute rule can be applied in any series of cases. A guide to therapy is offered through the posing of three questions regarding the warranty of surgical intervention, proper time for surgery and operative ...
U, MAES, G N, WEISS
openaire +2 more sources